Back to Search Start Over

Antifungal Agents Based on Chitosan Oligomers, ε-polylysine and Streptomyces spp. Secondary Metabolites against Three Botryosphaeriaceae Species

Authors :
M. Carmen Ramos-Sánchez
José L. Revuelta
Pablo Martín-Ramos
Eduardo Pérez-Lebeña
David Ruano-Rosa
Jesús Martín-Gil
José Casanova-Gascón
Laura Buzón-Durán
Source :
Antibiotics, Vol 8, Iss 3, p 99 (2019), UVaDOC. Repositorio Documental de la Universidad de Valladolid, instname, Antibiotics, GREDOS: Repositorio Institucional de la Universidad de Salamanca, Universidad de Salamanca (USAL), Volume 8, Issue 3, GREDOS. Repositorio Institucional de la Universidad de Salamanca
Publication Year :
2019
Publisher :
MDPI AG, 2019.

Abstract

Grapevine trunk diseases (GTDs) are a major threat to the wine and grape industry. The aim of the study was to investigate the antifungal activity against Neofusicoccum parvum, Diplodia seriata, and Botryosphaeria dothidea of &epsilon<br />polylysine, chitosan oligomers, their conjugates, Streptomyces rochei and S. lavendofoliae culture filtrates, and their binary mixtures with chitosan oligomers. In vitro mycelial growth inhibition tests suggest that the efficacy of these treatments, in particular those based on &epsilon<br />polylysine and &epsilon<br />polylysine:chitosan oligomers 1:1 w/w conjugate, against the three Botryosphaeriaceae species would be comparable to or higher than that of conventional synthetic fungicides. In the case of &epsilon<br />polylysine, EC90 values as low as 227, 26.9, and 22.5 &micro<br />g&middot<br />mL&minus<br />1 were obtained for N. parvum, D. seriata, and B. dothidea, respectively. Although the efficacy of the conjugate was slightly lower, with EC90 values of 507.5, 580.2, and 497.4 &micro<br />1, respectively, it may represent a more cost-effective option to the utilization of pure &epsilon<br />polylysine. The proposed treatments may offer a viable and sustainable alternative for controlling GTDs.

Details

Language :
English
ISSN :
20796382
Volume :
8
Issue :
3
Database :
OpenAIRE
Journal :
Antibiotics
Accession number :
edsair.doi.dedup.....618cb967f285d65a5c8e5ba508e122bd